|
|
Usage: As a cyclic guanosine monophosphate (cGMP) specific phosphodiesteras...
|
2013-03-06
|
| Assay: 99% min. USP32
|
|
|
|
Sildenafil (Viagra) (Steroids)
CAS: 139755-83-2
Assay: 99% min.
...
|
2015-08-21
|
| Sildenafil (Viagra) (Steroids)
|
|
|
|
As a cyclic guanosine monophosphate (cGMP) specific phosphodiesterase type ...
|
2015-07-14
|
| Sildenafil (Viagra) (Steroids)
|
|
|
|
Usage: As a cyclic guanosine monophosphate (cGMP) specific phosphodiesteras...
|
2014-12-20
|
| C22H30N6O4S
|
|
|
|
Usage: As a cyclic guanosine monophosphate (cGMP) specific phosphodiesteras...
|
2014-05-07
|
| Sildenafil (Viagra) (Steroids)
|
|
|
|
Sildenafil (Viagra)
CAS: 139755-83-2
Assay: 99% min. USP32
Packing: 1k...
|
2012-12-07
|
| Sildenafil (Viagra)
|
|
|
|
Sildenafil (Viagra)
CAS: 139755-83-2
Assay: 99% min. USP32
Packi...
|
2013-01-07
|
| 99% min. USP32
|
|
|
|
Molecular Formula C22H30N6O4S
Molecular Weight 474.5764
CAS Registry Nu...
|
2012-04-25
|
| Sildenafil
|
|
|
|
It is pharmaceutical raw material, indicated for the treatment of erectile ...
|
2011-08-04
|
| Sildenafil
|
|
|
|
Usage: to treatment penile erectile dysfunction (ED)
|
2011-10-19
|
| sildenafil citrate
|
|
|
|
An orally active selective type 5 cGMP phosphodiesterase inhibitor
|
2015-08-13
|
| White Solid
|
|
|
|
indicated for the treatment of erectile dysfunction.
|
2008-12-08
|
| Sildenafil Citrate
|
|
|
|
Sildenafil Citrate
CAS#: 139755-83-2
Dosage: As with all prescription dru...
|
2012-12-13
|
| Sildenafil Citrate
|
|
|
|
Sildenafil citrate
CAS: 171599-83-0
Assay: 99% min. USP32
Packing: 1kg/...
|
2012-12-13
|
| Sildenafil citrate
|
|
|
|
Sildenafil Citrate
CAS#: 139755-83-2
Dosage: As with all prescription dru...
|
2012-12-07
|
| Sildenafil Citrate
|
|
|
|
Sildenafil citrate
CAS: 171599-83-0
Assay: 99% min. USP32
Packing: 1kg/...
|
2012-12-07
|
| Sildenafil citrate
|
|
|
|
pharmaceutical
|
2013-01-24
|
| Sildenafil citrate
|
|
|
|
An orally active selective type 5 cGMP phosphodiesterase inhibitor
|
2012-05-30
|
| Sildenafil citrate
|
|
|
|
Sildenafil Citrate
CAS#: 139755-83-2
Dosage: As with all prescription dru...
|
2013-01-24
|
| Sildenafil Citrate
|
|
|
|
Sildenafil citrate
CAS: 171599-83-0
Assay: 99% min. USP32
Packing...
|
2013-01-07
|
| Sildenafil citrate
|
|
|
|
An orally active selective type 5 cGMP phosphodiesterase inhibitor.
|
2012-06-21
|
| Sildenafil Citrate
|
|
|
|
Assays: 99%
Packaging: 1kg/foil bag
|
2015-08-26
|
| Sildenafil citrate
|
|
|
|
Sildenafil citrate
Product name: Sildenafil citrate
Synonym: Viagra
CAS ...
|
2015-09-22
|
| Sildenafil citrate
|
|
|
|
An orally active selective type 5 cGMP phosphodiesterase inhibitor
|
2015-08-21
|
| White Solid
|
|
|
|
sex enhancers
|
2013-01-16
|
| 139755-83-2
|
|
|
|
It is a drug used to treat erectile
dysfunction and pulmonary arterial ...
|
2010-05-19
|
| C22H30N6O4S
|
|
|
|
Sildenafil citrate
CAS: 171599-83-0
Character: Sildenafil citrate, sild...
|
2012-04-25
|
| Sildenafil citrate
|
|
|
|
Sildenafil citrate
CAS: 171599-83-0
Character: Sildenafil citrate, sild...
|
2012-04-25
|
| Sildenafil citrate
|
|
|
|
Sildenafil citrate (Steroids)
CAS: 171599-83-0
Assay: 99% min. USP...
|
2015-04-15
|
| Sildenafil citrate
|
|
|
|
Products Manufactured by us are as follows
Artesunate
Alpha Beta Art...
|
2005-10-24
|
| Sildenafil Citrate
|
|
|
|
for health
|
2013-02-04
|
| 98%
|
|
|
|
An orally active selective type 5 cGMP phosphodiesterase inhibitor. pharmac...
|
2013-06-27
|
| Sildenafil Citrate
|
|
|
|
An orally active selective type 5 cGMP phosphodiesterase inhibitor. pharmac...
|
2013-06-27
|
| Sildenafil Citrate
|
|
|
|
Usage: An orally active selective type 5 cGMP phosphodiesterase inhibitor. ...
|
2015-01-08
|
| Sildenafil citrate
|
|
|
|
Pharmaceutical
|
2013-01-24
|
| Sildenafil Citrate
|
|
|
|
Sildenafil Citrate
CAS#: 139755-83-2
Dosage: As with all prescription dru...
|
2013-01-24
|
| Sildenafil Citrate
|
|
|
|
An orally active selective type 5 cGMP phosphodiesterase inhibitor. pharmac...
|
2015-01-08
|
| White Solid
|
|
|
|
Sildenafil citrate
CAS: 171599-83-0
Assay: 99% min. USP32
Packing...
|
2013-01-07
|
| 99% min. USP32
|
|
|
|
indicated for the treatment of erectile dysfunction.
|
2011-08-04
|
| Sildenafil Citrate
|
|
|
|
Usage: An orally active selective type 5 cGMP phosphodiesterase inhibitor. ...
|
2014-05-07
|
| Sildenafil citrate (Steroids)
|
|
|
분야별분류: 의약,중간체
제품명순
